yingtiao
Lv14
60 积分
2022-11-10 加入
-
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
2天前
已完结
-
Alopecia Areata
2天前
已完结
-
Study of preventive treatment with combined theray in tuberulosis Children
2天前
已完结
-
Inhibiting Janus kinases to treat alopecia areata
23天前
已完结
-
Janus kinase inhibitors for alopecia areata
26天前
已完结
-
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
1个月前
已完结
-
Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open‐Label, Phase 1 Study
1个月前
已完结
-
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
1个月前
已完结
-
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
-
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
1个月前
已完结